Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Single-blind, Sham-controlled Clinical Trial to Evaluate the Safety and Effectiveness of Targeted Lung Denervation Radiofrequency Ablation Devices in the Treatment of Chronic Obstructive Pulmonary Disease

NCT05799664 is registered in ClinicalTrials.gov with Hangzhou Broncus Medical Co., Ltd. as lead sponsor.

NCT NCT05799664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05799664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Single-blind, Sham-controlled Clinical Trial to Evaluate the Safety and Effectiveness of Targeted Lung Denervation Radiofrequency Ablation Devices in the Treatment of Chronic Obstructive Pulmonary Disease
Lead sponsor
Hangzhou Broncus Medical Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
July 4, 2023
Completion date
June 30, 2028
Enrollment
189 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd